MYL

Mylan Inc. News Headlines

$48.39
*  
0.64
1.34%
Get MYL Alerts
*Delayed - data as of Aug. 22, 2014 13:55 ET  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MYL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Actavis Settles with Valeant - Analyst Blog
4/11/2013 1:09:46 PM - Zacks.com

TRO on Actavis Sale of Generic Pulmicort Respules - Analyst Blog
4/10/2013 10:50:01 AM - Zacks.com

Valeant Inks Deal with Actavis - Analyst Blog
4/8/2013 5:07:27 PM - Zacks.com

Can Teva's Short-Term Pressure Be Justified?
4/5/2013 3:05:00 PM - Seeking Alpha

Setback for Valeant Pharma - Analyst Blog
4/5/2013 1:09:47 PM - Zacks.com

Dr. Reddy's Launches Generic Reclast - Analyst Blog
4/4/2013 7:06:11 PM - Zacks.com

Another Generic Launch at Mylan - Analyst Blog
4/4/2013 3:09:14 PM - Zacks.com

Teva's Quartette Approved in the US - Analyst Blog
4/4/2013 10:08:29 AM - Zacks.com

KaloBios Pharma Incurs Wider Loss - Analyst Blog
4/3/2013 1:22:08 PM - Zacks.com

Perrigo Touches 52-Week High - Analyst Blog
4/3/2013 9:23:05 AM - Zacks.com

Perrigo Buys Velcera - Analyst Blog
4/2/2013 5:24:35 PM - Zacks.com

Dr. Reddy's Launches Generic Accutane - Analyst Blog
4/1/2013 5:11:48 PM - Zacks.com

Actavis/AZN Settle Crestor Litigation - Analyst Blog
3/26/2013 4:24:45 PM - Zacks.com

Data on Teva's Azilect - Analyst Blog
3/25/2013 7:26:35 PM - Zacks.com

Back to Neutral on Warner Chilcott - Analyst Blog
3/21/2013 2:32:22 PM - Zacks.com

Good News for Mylan's Generic Unit - Analyst Blog
3/20/2013 1:46:54 PM - Zacks.com

Mylan Settles Patent Dispute - Analyst Blog
3/14/2013 2:13:18 PM - Zacks.com

Actavis in Patent Challenge - Analyst Blog
3/11/2013 5:12:02 PM - Zacks.com

Teva Enrolls Patients in MS Study - Analyst Blog
3/8/2013 4:50:01 PM - Zacks.com

EU Approves Roche's Perjeta - Analyst Blog
3/7/2013 1:10:01 PM - Zacks.com

This Little-Known Stock Could Double Thanks To The 'Patent Cliff'
3/6/2013 7:39:00 PM - Seeking Alpha

Setback for Impax, Shares Plunge - Analyst Blog
3/6/2013 6:55:01 PM - Zacks.com

Patent Relief for Pfizer - Analyst Blog
3/6/2013 5:15:01 PM - Zacks.com

Good News for Pernix Therapeutics - Analyst Blog
3/5/2013 5:55:06 PM - Zacks.com

Actavis Files ANDA for Endo Product - Analyst Blog
3/5/2013 5:40:01 PM - Zacks.com